That the combination of Upk1a/Upk1b and GATA3 resulted in an even stronger association with patient survival and that this link was still completely limited to pT4 cancers may suggest that IHC panels identifying luminal type pT4 carcinomas may have clinical utility in the future. This evidence concerns the gene UPK1B and carcinoma.